» Articles » PMID: 37398646

Quantum Vaccinomics Platforms to Advance in Vaccinology

Overview
Journal Front Immunol
Date 2023 Jul 3
PMID 37398646
Authors
Affiliations
Soon will be listed here.
Abstract

The opinion flows from Introduction to the immunological quantum that requires a historical perspective, to Quantum vaccine algorithms supported by a bibliometric analysis, to Quantum vaccinomics describing from our perspective the different vaccinomics and quantum vaccinomics algorithms. Finally, in the Discussion and conclusions we propose novel platforms and algorithms developed to further advance on quantum vaccinomics. In the paper we refer to protective epitopes or immunological quantum for the design of candidate vaccine antigens, which may elicit a protective response through both cellular and antibody mediated mechanisms of the host immune system. Vaccines are key interventions for the prevention and control of infectious diseases affecting humans and animals worldwide. Biophysics led to quantum biology and quantum immunology reflecting quantum dynamics within living systems and their evolution. In analogy to quantum of light, immune protective epitopes were proposed as the immunological quantum. Multiple quantum vaccine algorithms were developed based on omics and other technologies. Quantum vaccinomics is the methodological approach with different platforms used for the identification and combination of immunological quantum for vaccine development. Current quantum vaccinomics platforms include , and algorithms and top trends in biotechnology for the identification, characterization and combination of candidate protective epitopes. These platforms have been applied to different infectious diseases and in the future should target prevalent and emerging infectious diseases with novel algorithms.

Citing Articles

Modelling protein-protein interactions for the design of vaccine chimeric antigens with protective epitopes.

Contreras M, Rafael M, Sobrino I, Almazan C, Pastor Comin J, Valdes J PLoS One. 2025; 20(2):e0318439.

PMID: 39928697 PMC: 11809815. DOI: 10.1371/journal.pone.0318439.


Evolution of tick vaccinology.

de la Fuente J, Ghosh S Parasitology. 2024; 151(9):1045-1052.

PMID: 38586999 PMC: 11770523. DOI: 10.1017/S003118202400043X.


Perception of Ticks and Tick-Borne Diseases Worldwide.

de la Fuente J, Estrada-Pena A, Rafael M, Almazan C, Bermudez S, Abdelbaset A Pathogens. 2023; 12(10).

PMID: 37887774 PMC: 10610181. DOI: 10.3390/pathogens12101258.

References
1.
McFadden J, Al-Khalili J . The origins of quantum biology. Proc Math Phys Eng Sci. 2019; 474(2220):20180674. PMC: 6304024. DOI: 10.1098/rspa.2018.0674. View

2.
Galili U . Increasing Efficacy of Enveloped Whole-Virus Vaccines by In situ Immune-Complexing with the Natural Anti-Gal Antibody. Med Res Arch. 2021; 9(7). PMC: 8631339. DOI: 10.18103/mra.v9i7.2481. View

3.
Contreras M, Artigas-Jeronimo S, Pastor Comin J, de la Fuente J . A Quantum Vaccinomics Approach Based on Protein-Protein Interactions. Methods Mol Biol. 2021; 2411:287-305. DOI: 10.1007/978-1-0716-1888-2_17. View

4.
van Regenmortel M . Development of a Preventive HIV Vaccine Requires Solving Inverse Problems Which Is Unattainable by Rational Vaccine Design. Front Immunol. 2018; 8:2009. PMC: 5776009. DOI: 10.3389/fimmu.2017.02009. View

5.
Poland G, Kennedy R, Ovsyannikova I . Vaccinomics and personalized vaccinology: is science leading us toward a new path of directed vaccine development and discovery?. PLoS Pathog. 2012; 7(12):e1002344. PMC: 3248557. DOI: 10.1371/journal.ppat.1002344. View